Vijender Panduga

发表

Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis.

Christopher B. Cooper, Amit K. Gupta, D. Murray, 2017, Journal of medicinal chemistry.

Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway

Amit K. Gupta, G. Balakrishnan, A. Narayan, 2016 .

Ipratropium is 'luminally recycled' by an inter-play between apical uptake and efflux transporters in Calu-3 bronchial epithelial cell layers.

C. Bosquillon, Michael J. Stocks, Vijender Panduga, 2017, International journal of pharmaceutics.

Effect of repeated dosing on rifampin exposure in BALB/c mice.

Vijay T. Ahuja, S. Ganguly, J. Reddy, 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing.

V. Sambandamurthy, Sreevalli Sharma, J. Reddy, 2014, ACS medicinal chemistry letters.

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate

D. Wirth, D. Fidock, Pavithra Viswanath, 2015, Nature Communications.

Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.

Vijay T. Ahuja, D. Ogg, J. Tucker, 2013, Journal of medicinal chemistry.

4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.

J. Mckinney, L. Chiarelli, N. Dhar, 2014, Journal of medicinal chemistry.

Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.

Vijay T. Ahuja, A. Srivastava, A. Narayan, 2013, Journal of medicinal chemistry.

1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis

Christopher B. Cooper, S. Narayanan, C. Cooper, 2014, Antimicrobial Agents and Chemotherapy.

Lead optimization of 1,4-azaindoles as antimycobacterial agents.

Christopher B. Cooper, S. Butler, A. Srivastava, 2014, Journal of medicinal chemistry.

Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.

Christopher B. Cooper, S. Butler, A. Narayan, 2019, ACS medicinal chemistry letters.

N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.

D. Fidock, F. Gamo, A. Srivastava, 2014, Journal of medicinal chemistry.

Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.

D. Wirth, F. Gamo, Pavithra Viswanath, 2014, Journal of medicinal chemistry.

In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis

Vijay T. Ahuja, V. Ramachandran, R. Shandil, 2013, Antimicrobial Agents and Chemotherapy.

In Silico-Based High-Throughput Screen for Discovery of Novel Combinations for Tuberculosis Treatment

Anima Anandkumar, S. Narayanan, V. Ramachandran, 2015, Antimicrobial Agents and Chemotherapy.

Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis

Anirban Ghosh, K. Mukherjee, V. Subbulakshmi, 2013, Antimicrobial Agents and Chemotherapy.

Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.

Anirban Ghosh, K. Mukherjee, S. Hoffner, 2014, Journal of medicinal chemistry.

In vitro and in vivo efficacy of beta-lactams against replicating and slowly 1 growing/non replicating M. tuberculosis 2

Vijay T. Ahuja, V. Ramachandran, R. Shandil, 2013 .